Attention-deficit/hyperactivity disorder and substance abuse.
paper
Cited
Public
Unavailable
- Authors
- Harstad, Elizabeth; Levy, Sharon; Committee on Substance Abuse
- Year
- 2014
- Journal
- Pediatrics
- PMID
- 24982106
- DOI
- 10.1542/peds.2014-0992
Attention-deficit/hyperactivity disorder (ADHD) and substance use disorders are inextricably intertwined. Children with ADHD are more likely than peers to develop substance use disorders. Treatment with stimulants may reduce the risk of substance use disorders, but stimulants are a class of medication with significant abuse and diversion potential. The objectives of this clinical report were to present practical strategies for reducing the risk of substance use disorders in patients with ADHD and suggestions for safe stimulant prescribing.
No figures extracted from this document.
No chunks — full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| Genome-wide association study of stimulant dependence. | 2021 | 34226506 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Complex Attention-Deficit Hyperactivity Disorder in a 15-year-old With a Substance Use Disorder. | Simon KM et al. | — | 2026 | → |
| Adolescent-Reported Changes in Provider Behavior Following Pediatrician Training in Stimulant Diversion Prevention: Results From a Cluster Randomized Controlled Trial. | Molina BSG et al. | — | 2025 | → |
| Comparison of serious adverse effects of methylphenidate, atomoxetine and amphetamine in the treatment of ADHD: an adverse event analysis based on the FAERS database. | Wu L et al. | — | 2025 | → |
| Development of a brief inpatient curriculum to enhance trainee skills in assessment and treatment of adolescents with substance use and co-occurring mental health problems. | Becker TD et al. | — | 2025 | → |
| Nitrous oxide use and psychiatric disorders: a retrospective clinical cohort study on prevalence and patterns. | Paetow R et al. | — | 2025 | → |
| Recent Trends in Medication Treatment for Attention-Deficit Hyperactivity Disorder. | Huskamp HA et al. | — | 2025 | → |
| Sex differences in reward network activation are linked to problematic substance use among high-risk adolescents. | Murray OK et al. | — | 2025 | → |
| The long way to diagnosis: attention disorder, alcohol addiction or congenital disorder of glycosylation? A case report. | Faustmann TJ et al. | — | 2025 | → |
| Clinical and Neuropsychological Correlates of Substance Use Disorders in a Sample of Egyptian Adolescents with Attention Deficit Hyperactivity Disorder | Arafa OE et al. | — | 2024 | — |
| Diagnosis and Treatment of ADHD in the Pediatric Population. | Eiland LS et al. | — | 2024 | → |
| Early-life risperidone alters locomotor responses to apomorphine and quinpirole in adulthood. | Bardgett ME et al. | — | 2024 | → |
| Nonmedical Use of Controlled Medications by Adolescents and Young Adults: Clinical Report. | Chadi N et al. | — | 2024 | → |
| Adolescent Substance Use Disorders. | Simon KM et al. | — | 2022 | → |
| Treatment retention in opioid agonist therapy: comparison of methadone versus buprenorphine/naloxone by analysis of daily-witnessed dispensed medication in a Canadian Province. | Sadek J et al. | — | 2022 | → |
| Association of Tourette Syndrome and Chronic Tic Disorder With Subsequent Risk of Alcohol- or Drug-Related Disorders, Criminal Convictions, and Death: A Population-Based Family Study. | Virtanen S et al. | — | 2021 | → |
| Evaluation of Attention-Deficit/Hyperactivity Disorder Medications, Externalizing Symptoms, and Suicidality in Children. | Shoval G et al. | — | 2021 | → |
| Genome-wide association study of stimulant dependence. | Cox J et al. | — | 2021 | → |
| Perspectives of US Adolescents on Diverted Stimulant Use. | Hadler N et al. | — | 2021 | → |
| Randomized Trial of Academic Training and Medication Decision-Making for Adolescents with ADHD in Usual Care. | Hogue A et al. | — | 2021 | → |
| Sensitivity and specificity of S2BI for identifying alcohol and cannabis use disorders among adolescents presenting for primary care. | Levy S et al. | — | 2021 | → |
| Symptoms of Internet Gaming Disorder, Inattention, and Impulsivity: a Cross-Sectional Study Conducted in the United Arab Emirates. | Vally Z | — | 2021 | → |
| US Emergency Department Visits Attributed to Medication Harms, 2017-2019. | Budnitz DS et al. | — | 2021 | → |
| Chronic risperidone administration leads to greater amphetamine-induced conditioned place preference. | Bardgett ME et al. | — | 2020 | → |
| Exploring substance use disorders and relapse in Mauritian male addicts. | Ramsewak S et al. | — | 2020 | → |
| Prevalence and social determinants of psychological distress among people who use drugs in Cambodia. | Saing CH et al. | — | 2020 | → |
| Society for Developmental and Behavioral Pediatrics Clinical Practice Guideline for the Assessment and Treatment of Children and Adolescents with Complex Attention-Deficit/Hyperactivity Disorder. | Barbaresi WJ et al. | — | 2020 | → |
| The importance of anti-vaping vigilance-EVALI in seven adolescent pediatric patients in Northeast Ohio. | Corcoran A et al. | — | 2020 | → |
| Treatments for Adolescents With Comorbid ADHD and Substance Use Disorder: A Systematic Review. | Zaso MJ et al. | — | 2020 | → |
| Adolescent and Parent Management of Controlled Prescription Medications. | Engster SA et al. | — | 2019 | → |
| Association between pharmacotherapy for ADHD in offspring and depression-related specialty care visits by parents with a history of depression. | Chen Q et al. | — | 2019 | → |
| Associations between attention deficit hyperactivity and internet gaming disorder symptoms: Is there consistency across types of symptoms, gender and countries? | Stavropoulos V et al. | — | 2019 | → |
| Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents. | Wolraich ML et al. | — | 2019 | → |
| Medicine, with a focus on physicians: Addressing substance use in the 21st century. | Levy S et al. | — | 2019 | → |
| Personal and Socioeconomic Determinants in Medication-assisted Treatment of Opioid Use Disorder in Adolescents and Young Adults. | Grubb LK | — | 2019 | → |
| The Effect of High-Intensity Interval/Circuit Training on Cognitive Functioning and Quality of Life During Recovery From Substance Abuse Disorder. A Study Protocol. | Andreassen Ø et al. | — | 2019 | → |
| Treatment strategies for ADHD: an evidence-based guide to select optimal treatment. | Caye A et al. | — | 2019 | → |
| Impulsivity in Alcohol-Dependent Patients with and without ADHD: The Role of Atomoxetine. | Coppola M et al. | — | 2018 | → |
| [Prevalence of neurodevelopmental, behavioural and learning disorders in Pediatric Primary Care]. | Carballal Mariño M et al. | — | 2018 | → |
| The relationship between internet addiction, attention deficit hyperactivity symptoms and online activities in adults. | Panagiotidi M et al. | — | 2018 | → |
| A Clinician's Guide to Co-occurring ADHD among Adolescent Substance Users: Comorbidity, Neurodevelopmental Risk, and Evidence-based Treatment Options. | Hogue A et al. | — | 2017 | → |
| An update on the safety of psychostimulants for the treatment of attention-deficit/hyperactivity disorder. | Groenman AP et al. | — | 2017 | → |
| Association of Risk of Suicide Attempts With Methylphenidate Treatment. | Man KKC et al. | — | 2017 | → |
| Distance-Learning, ADHD Quality Improvement in Primary Care: A Cluster-Randomized Trial. | Fiks AG et al. | — | 2017 | → |
| Early-life risperidone enhances locomotor responses to amphetamine during adulthood. | Lee Stubbeman B et al. | — | 2017 | → |
| Lost in transition: A review of the unmet need of patients with attention deficit/hyperactivity disorder transitioning to adulthood. | Treuer T et al. | — | 2017 | → |
| Neuroimaging the neural correlates of increased risk for substance use disorders in attention-deficit/hyperactivity disorder-A systematic review. | Adisetiyo V et al. | — | 2017 | → |
| Physician practices to prevent ADHD stimulant diversion and misuse. | Colaneri N et al. | — | 2017 | → |
| Psychotropic Medication Use among Insured Children with Autism Spectrum Disorder. | Madden JM et al. | — | 2017 | → |
| The evaluation of a question prompt list for attention-deficit/hyperactivity disorder in pediatric care: A pilot study. | Ahmed R et al. | — | 2017 | → |
| ADHD in school-aged youth: Management and special treatment considerations in the primary care setting. | Weed ED | — | 2016 | → |
| Developmental stress elicits preference for methamphetamine in the spontaneously hypertensive rat model of attention-deficit/hyperactivity disorder. | Womersley JS et al. | — | 2016 | → |
| Excessive Sensory Stimulation during Development Alters Neural Plasticity and Vulnerability to Cocaine in Mice. | Ravinder S et al. | — | 2016 | → |
| Methylphenidate and the risk of psychotic disorders and hallucinations in children and adolescents in a large health system. | Man KK et al. | — | 2016 | → |
| Pharmacotherapy for Substance Use Disorders in Youths. | Hammond CJ et al. | — | 2016 | → |
| Psychiatric Comorbidity and Complications. | Mason MJ et al. | — | 2016 | → |
| The potential for misuse and abuse of medications in ADHD: a review. | Clemow DB et al. | — | 2014 | → |